Innovative Hematology, Inc.

Indianapolis, Indiana 46260

3 studies enrolling now · 5 studies all time

What they study most

Hemophilia A, Hemophilia B, Hereditary Hemorrhagic Telangiectasia (HHT), Immune Thrombocytopenic Purpura (ITP)

Studies at this site

• A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
• A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia — Recruiting now
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B — Running, not enrolling
• A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia — Withdrawn before enrolling